epithalon oral dosing Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties Epithalon | Next Gen Peptides

DSIP may more broadly influence deep sleep architecture and stress response Benzodiazepines carry significant risks of dependency and cognitive side effects

Our findings indicate that FOXO4-DRI promotes apoptosis in senescent cells by disrupting the FOXO4-P53 interaction, thereby releasing and phosphorylating P53, which then translocates to the cytoplasm

Store lyophilized peptides at -20C, protected from light and moisture

Dosing Protocol A suggested titration approach based on common reference doses for GHK-Cu

Tumor risk via p53 pathway interference Mitigate risk by: Careful patient selection: exclude patients with pre-existing active malignancy or high tumour risk (e.g., known p53 mutations, familial cancer syndromes)

Treat the following as community-derived hypotheses, not validated outcomes: Hypothesis 1 Plateau breaking past retatrutide monotherapy Community framing is that adding cagrilintide engages a receptor system retatrutide does not target, which could theoretically extend weight loss past a retatrutide-monotherapy plateau